Investor Alert

Company Close Updates Archives | Email alerts

Jan. 26, 2021, 5:06 p.m. EST

BioNTech SE ADR underperforms Tuesday when compared to competitors

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

The BioNTech SE ADR BNTX slid 3.91% to $106.29 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.15% to 3,849.62 and Dow Jones Industrial Average DJIA falling 0.07% to 30,937.04. The ADR's fall snapped a three-day winning streak. BioNTech SE ADR closed $24.71 short of its 52-week high ($131.00), which the company achieved on December 11th.

The ADR underperformed when compared to some of its competitors Tuesday, as AbbVie Inc. ABBV fell 1.54% to $108.80 and Amgen Inc. AMGN rose 0.58% to $258.60. Trading volume (3.9 M) remained 286,639 below its 50-day average volume of 4.1 M.

Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.